title: Haemodynamic sequelae of pulmonary fibrosis following intratracheal bleomycin in rats.
abstract: OBJECTIVE
  Intratracheal instillation of bleomycin in rats has been extensively used as an animal model of pulmonary fibrosis in humans, although it produces a patchy, airway based response. We proposed that the haemodynamic sequelae of the bleomycin model might be less severe than those associated with more diffuse lung injury.
  
  
  METHODS
  Pulmonary and systemic haemodynamic indices were examined in adult Sprague-Dawley rats (approximately 400 g, n = 10) both at rest and during submaximal exercise on a rodent treadmill, approximately 60 days after intratracheal bleomycin (6 units.kg-1), and the results compared to a control group (n = 6).
  
  
  RESULTS
  Compared to controls, mean pulmonary artery pressure (PPA) was increased by intratracheal bleomycin (p = 0.02) both at rest [24.5 (SEM 2.6) v 18.2(0.9) mm Hg] and during exercise [34.7(3.0) v 26.7(0.7) mm Hg]. PPA-pulse product was also increased, with a similar trend in right ventricular work index, but cardiac index was not altered. Right ventricular hypertrophy was noted on necropsy examination. Consistent with pulmonary fibrosis, lung dry weight, total protein, and hydroxyproline were also raised, and these values correlated strongly with (mean) PPA at rest (r2 = 0.86, 0.81, 0.69, respectively) and during exercise (r2 = 0.81, 0.79, 0.65, respectively). Packed cell volume was increased by intratracheal bleomycin, at 49(1) v 45(1)%, p = 0.02. CaO2 tended to decrease with exercise in the bleomycin group, although this was not statistically significant, while systemic oxygen delivery and consumption were not altered.
  
  
  CONCLUSIONS
  Pulmonary hypertension and right ventricular hypertrophy occur in this model of lung fibrosis, and correlate with the severity of fibrosis. However, these sequelae were less severe than those previously demonstrated in association with crotalaria ingestion. We suggest that the haemodynamic sequelae of the intratracheal bleomycin model are consistent with patchy, airway based fibrosis, but reflect less well the haemodynamic sequelae of more diffuse fibrotic injury associated with systemic processes.
authors.affiliation: University of California Irvine, Medical Center, Orange 92668.
authors.forename: J H
authors.initials: JH
authors.lastname: Williams
authors.forename: P
authors.initials: P
authors.lastname: Bodell
authors.forename: S
authors.initials: S
authors.lastname: Hosseini
authors.forename: H
authors.initials: H
authors.lastname: Tran
authors.forename: K M
authors.initials: KM
authors.lastname: Baldwin
mesh_terms: D000818:Animals; D001761:Bleomycin / Q000494:pharmacology*; D006332:Cardiomegaly / Q000139:chemically induced; D004195:Disease Models, Animal; D006400:Hematocrit; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced; D007322:Instillation, Drug; D037102:Lectins; D008168:Lung / Q000187:drug effects; D005082:Physical Exertion; D037121:Plant Lectins; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D037102:Lectins; D037121:Plant Lectins; C070531:crotalarin; D001761:Bleomycin